Skip to main content

Texas Medical Center selects 11 medtech companies for accelerator program

The program connects entrepreneurs to researchers, hospital experts and advisors to address unmet clinical needs.
By Jeff Lagasse , Editor
Computer networks stretching across a cityscape

Photo: Weiquan Lin/Getty Images

Texas Medical Center Innovation has picked 11 startups for a six-month program that helps to advance clinical and commercial development for early stage medtech companies.

The HealthTech Accelerator program of Texas Medical Center brings entrepreneurs from around the world to the TMC Innovation Factory, connecting them with researchers, hospital experts and seasoned advisors to address unmet clinical needs.

The program is meant to support entrepreneurs in further developing their companies by bringing industry leaders to hone participants’ approaches to clinical trials, regulatory strategy, data security, hospital procurement, intellectual property, fundraising, marketing and other areas.

The chosen cohort of participants starts the program on Nov. 3 for an inaugural session dedicated to preliminary customer discovery and clinical validation.

Then they will spend five months in the “incubator,” where founders will benefit from working closely with TMC specialists to refine their go-to-market plan.

“This cohort of startups is tackling some of today’s most pressing clinical challenges, from surgery and respiratory care to diagnostics and women’s health,” said Tom Luby, chief innovation officer at Texas Medical Center. “At TMC, we bring together the minds behind innovation – entrepreneurs, technology leaders, and strategic partners – to help emerging companies validate, scale, and deliver solutions that make a real difference for patients here and around the world.”

WHAT'S THE IMPACT 

Eleven companies have been picked to comprise the initial cohort.

OsseoLabs develops AI-assisted, 3D-printed patient-specific implants for craniofacial and orthopedic surgeries. Roam Technologies pioneers tankless oxygen generation devices for chronic respiratory care, while SageSpectra designs a patch system for real-time, remote monitoring of temperature and StO2 for assessing vascular occlusion, infection and other surgical flap complications.

OptiLung develops 3D-printed extracorporeal blood oxygenation devices designed to optimize blood flow; Dozee created a smart remote patient monitor platform that uses under-the-mattress bed sensors to capture vital signs through continuous monitoring.

Other cohort members include imaging company Dynamic Light; biosurgical device manufacturer Endomedix; biomechanical company Xander Medical; pelvic floor monitoring company Freyya; imaging catheter outfit Scinvivo; and cardiopulmonary platform Respiree.

THE LARGER TREND: ON THE RECORD 

“Every year, we see new innovations that have the potential to transform how people experience healthcare,” said Devin Dunn, director of innovation accelerators at Texas Medical Center. “At TMC, we provide unparalleled expertise in clinical validation and commercialization strategy. This support helps startups refine and validate their technologies before bringing them to market, and ultimately to patients.”

 

Jeff Lagasse is editor of Healthcare Finance News.
Healthcare Finance News is a HIMSS Media publication.